CollPlant names new board chairman: 4 insights

Written by Jackie Drees | February 04, 2019 | Print  |

Regenerative medicine company CollPlant appointed Jonathan M.N. Rigby as chairman of the board of directors.

Four insights:

1. Mr. Rigby brings more than 28 years of experience in the pharmaceutical, biopharmaceutical, medical device and drug delivery industries to CollPlant.

2. Previously, Mr. Rigby was president and CEO of SteadyMed, a specialty pharmaceutical company that United Therapeutics bought in August 2018.

3. Along with his new role at CollPlant, Mr. Rigby will continue to serve as president and CEO of SteadyMed, a United Therapeutics corporation.

4. CollPlant focuses on 3D bioprinting of tissues and organs, medical aesthetics and the development and commercialization of tissue repair products for orthobiologics.

More articles on biologics:
Ortho RTi releases results of 2 regenerative medicine studies
California neuroscience institute joins regenerative medicine clinical trial: 5 notes
ThermoGenesis makes orthopedic partnership: 3 notes

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months